Parent Willingness to Participate in Tobacco Trials in the Pediatric Clinical Setting
4 марта 2015 г. обновлено: St. Jude Children's Research Hospital
Tobacco Trials at St. Jude: Parent Willingness to Participate Among Families of Children With Cancer, Sickle Cell Disease, or Survivors of Childhood Cancer
Little is known about what factors influence parental decisions to participate or to decline participation in tobacco trials offered in the pediatric clinical setting.
Further, it is unclear what proportion of parents treated in our setting would elect to receive formal assistance with quitting smoking or consider alternative approaches that could facilitate eventual smoking cessation.
While the recommendation to parents is generally to quit smoking, some may be unwilling or unable to quit and prefer more achievable alternative treatment goals.
Some parent smokers may be unlikely to participate in an intervention aimed only at cessation but would be willing to participate in an intervention focused on establishing smoke-free environments for their child.
Parents are typically not offered a choice regarding the type of intervention they receive and many interventions are not tailored to their readiness to quit smoking or designed to reach multiple family members in the home who may also smoke.
Quitting smoking and establishing smoke-free homes and cars are distinct, yet challenging, goals for parents and families.
Both approaches can directly, or indirectly, help parents to quit smoking, reduce the child's exposure to second-hand smoke (SHS), and initiate an important dialogue with families about tobacco control.
How parental acceptability of smoking interventions is affected by the context of their child's treatment for cancer or SCD, as well as survivorship, warrants further study.
Обзор исследования
Статус
Завершенный
Условия
Вмешательство/лечение
Подробное описание
Following a Behavioral Ecological Model (BEM), this study will assess factors that influence parent's willingness to participate in tobacco trials that emphasize cessation or promotion of smoke-free homes/cars while identifying barriers for implementing these strategies. Information will be obtained from questionnaires completed by parents. This information will be used to suggest an appropriate emphasis for intervention, refine our recruitment strategies, design interventions that maximize participation rates and retention, and better direct our resources and future tobacco control efforts for patients and their families.
PRIMARY OBJECTIVE:
- To estimate the proportion of smoking parents of children with cancer, children with sickle cell disease (SCD), and childhood cancer survivors who are willing to participate in tobacco trials offered in the context of their child's medical care.
Тип исследования
Наблюдательный
Регистрация (Действительный)
88
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Места учебы
-
-
Tennessee
-
Memphis, Tennessee, Соединенные Штаты, 38105
- St. Jude Children's Research Hospital
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Нет
Полы, имеющие право на обучение
Все
Метод выборки
Невероятностная выборка
Исследуемая популяция
For the purposes of this protocol, the term "parent" includes biological parents, step-parents, and legal guardians.
The primary study population will consist of parents of St. Jude Children's Research Hospital (SJCRH) patients with a diagnosis of (1) cancer or (2) sickle cell disease (to include genotypes HbSS, HbSC, HbSβ°thal, HbSβ+thal, HbSD, HbSO, Hb S/HPFH, HbSE), or (3) will be a surviving cancer patient.
Описание
CHILD INCLUSION CRITERIA:
- SJCRH patient with a diagnosis of cancer or sickle cell disease (to include genotypes HbSS, HbSC, HbSβ°thal, HbSβ+thal, HbSD, HbSO, Hb S/HPFH, HbSE).
- <18 years of age at time of enrollment.
- For patients with cancer, those who are at least one month from diagnosis (to include patients in active treatment section, as well as, survivors in After Completion of Therapy clinic).
CHILD EXCLUSION CRITERIA:
- For patients with cancer, those who have relapsed or had disease recurrence within the past month.
- For patients with cancer, those who have progressive disease.
- In medical crisis, as determined by consultation with the patient's primary care physician.
- On transplant service.
- On inpatient service or expected/scheduled inpatient admission (e.g. hospitalized).
- Experiencing current acute complications of sickle cell disease requiring hospitalization or an acute care visit (e.g., pain crises, acute chest syndrome, acute cerebrovascular events/stroke or active infection/fever, etc.).
PARENT INCLUSION CRITERIA:
- One parent, who is 18 years of age or older, per family of a SJCRH patient who meets criteria.
- Current smoker (defined as having smoked cigarettes in the past 30 days, as based on self-report.)
- Reads and speaks English.
- Has the cognitive capacity to complete study questionnaires.
- Willing and able to provide informed consent according to institutional guidelines.
PARENT EXCLUSION CRITERIA:
- In crisis or distress or have another disabling condition that would preclude participation as determined by consultation with patient's primary care physician and/or social worker prior to study enrollment.
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
Когорты и вмешательства
Группа / когорта |
Вмешательство/лечение |
|---|---|
|
Cancer
Parents of children with cancer will complete a questionnaire.
|
Questionnaire data will be collected one time from parents who enroll on the study during their child's regular clinical visit.
We will use a cross-sectional design to estimate the proportion of smoking parents of children with or surviving cancer, or sickle cell disease (SCD) who are willing to participate in tobacco trials, hypothetically offered in the context of their child's medical care.
We will also examine the contribution of sociodemographic, environmental, and psychosocial variables, as well as, smoking behaviors as they relate to a parent's willingness to participate in a tobacco-related study.
|
|
Sickle cell disease
Parents of children with sickle cell disease will complete a questionnaire.
|
Questionnaire data will be collected one time from parents who enroll on the study during their child's regular clinical visit.
We will use a cross-sectional design to estimate the proportion of smoking parents of children with or surviving cancer, or sickle cell disease (SCD) who are willing to participate in tobacco trials, hypothetically offered in the context of their child's medical care.
We will also examine the contribution of sociodemographic, environmental, and psychosocial variables, as well as, smoking behaviors as they relate to a parent's willingness to participate in a tobacco-related study.
|
|
Survivors
Parents of survivors of childhood cancer will complete a questionnaire.
|
Questionnaire data will be collected one time from parents who enroll on the study during their child's regular clinical visit.
We will use a cross-sectional design to estimate the proportion of smoking parents of children with or surviving cancer, or sickle cell disease (SCD) who are willing to participate in tobacco trials, hypothetically offered in the context of their child's medical care.
We will also examine the contribution of sociodemographic, environmental, and psychosocial variables, as well as, smoking behaviors as they relate to a parent's willingness to participate in a tobacco-related study.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Proportion of parents willing to participate in tobacco trials
Временное ограничение: Once, at enrollment
|
The proportion of parents who are willing to participate in a tobacco trial will be determined by affirmative responses to at least one of three questions that assess willingness to participate in a research study focused on smoking cessation, adoption of a smoke-free home and car, and/or enforcement and maintenance of a smoke-free home and car.
|
Once, at enrollment
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Следователи
- Главный следователь: James Klosky, PhD, St. Jude Children's Research Hospital
Публикации и полезные ссылки
Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования
1 сентября 2012 г.
Первичное завершение (Действительный)
1 июля 2014 г.
Завершение исследования (Действительный)
1 июля 2014 г.
Даты регистрации исследования
Первый отправленный
22 августа 2012 г.
Впервые представлено, что соответствует критериям контроля качества
24 августа 2012 г.
Первый опубликованный (Оценивать)
27 августа 2012 г.
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
5 марта 2015 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
4 марта 2015 г.
Последняя проверка
1 марта 2015 г.
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- XPD12-110 SMOBAN
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .
Клинические исследования Questionnaire
-
Assistance Publique - Hôpitaux de ParisЗавершенныйБолезнь Паркинсона | Дистонические расстройства | Функциональное двигательное расстройствоФранция
-
Far Eastern Memorial HospitalЗавершенный
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationРекрутингРасстройства поведения | Расстройство аутистического спектраШвейцария